
Soliqua
My Prescription
Payment
Select pharmacy




$172.99
$15.00 due at pharmacy
$172.99 - $15.00 = $157.99
$157.99 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$172.99
Print or send this coupon to your phone
Pay as little as $0 for Soliqua
Works with your insurance. Enroll in the manufacturer's savings program in a few steps.
About Soliqua
Drug Details
This medication combines insulin glargine and lixisenatide to manage high blood sugar in individuals with type 2 diabetes, alongside a suitable diet and exercise plan. Effectively controlling blood sugar levels can prevent complications such as kidney damage, blindness, nerve issues, loss of limbs, and sexual dysfunction. Additionally, proper diabetes management may reduce the risk of heart attack or stroke. Insulin glargine, a long-acting synthetic insulin, helps move glucose into cells for energy by maintaining a consistent insulin level. Lixisenatide mimics a natural hormone, promoting insulin release in response to elevated blood sugar levels, especially after meals, and reducing sugar production by the liver.
Price history for Soliqua
1, 3ML of 100-33UNT-MCG/ML
Average retail price for Soliqua
Average SaveHealth price for Soliqua
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Soliqua dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 3ML of 100-33UNT-MCG/ML | 1 Pen | $172.99 | $172.99 |
| 3ML of 100-33UNT-MCG/ML | 2 Pens | $340.99 | $170.50 |
| 3ML of 100-33UNT-MCG/ML | 3 Pens | $508.98 | $169.66 |
Soliqua FAQs
Soliqua and Ozempic are not the same. Soliqua is a combination of insulin glargine and lixisenatide, used to improve blood sugar control in adults with type 2 diabetes. Ozempic, on the other hand, contains semaglutide, which is a GLP-1 receptor agonist, also used to manage blood sugar levels in type 2 diabetes. They have different active ingredients and mechanisms of action.
Soliqua is a combination insulin product that contains insulin glargine, a long-acting insulin, and lixisenatide, a GLP-1 receptor agonist. It is used to improve blood sugar control in adults with type 2 diabetes.
Soliqua is primarily used to improve blood sugar control in adults with type 2 diabetes. While weight loss is not the primary purpose of Soliqua, some patients may experience weight loss as a side effect. However, individual results can vary, and it is important to follow a healthcare provider's guidance for managing weight and diabetes.
Soliqua should not be taken by individuals who have a personal or family history of medullary thyroid carcinoma or those with Multiple Endocrine Neoplasia syndrome type 2. It is also contraindicated in individuals with a known hypersensitivity to any of its components. Additionally, it should not be used by individuals with diabetic ketoacidosis or those who are under 18 years of age. It is important for patients to consult with their healthcare provider to determine if Soliqua is appropriate for their condition.
The choice between Soliqua and Ozempic depends on the individual's specific medical condition, treatment goals, and response to medication. Soliqua is a combination of insulin glargine and lixisenatide, while Ozempic is a GLP-1 receptor agonist. Each has its own benefits and potential side effects. A healthcare provider should evaluate the patient's medical history, current health status, and treatment objectives to determine the most appropriate option. It is important for patients to discuss with their healthcare provider to make an informed decision.